mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |